NoParrot NoParrot
Back to AI Fact Checks

Did the discovery in 2015 link alpha-synuclein prions to multiple system atrophy (MSA)?

NoParrot Fact Check · September 19, 2026

Fact-checked by NoParrot's 4-model methodology · Last verified September 19, 2026

Want to fact-check your own claim? Try NoParrot Free
25

NoParrot Score

Mixed signals

Claim breakdown

Verified
0
Uncertain
1
Disputed
0

Synthesis

A significant discovery in 2015 linked alpha-synuclein prions to multiple system atrophy (MSA). In this year, researchers demonstrated that aggregated alpha-synuclein in the brains of MSA patients behaves like a prion, capable of transmitting the disease to cell cultures and transgenic mice. This work provided evidence that multiple system atrophy is caused by a prion form of alpha-synuclein, with brain extracts from MSA patients behaving in a self-propagating manner characteristic of prions. This research, led by Dr. Stanley Prusiner and his team, further distinguished MSA from Parkinson's disease, which also involves alpha-synuclein aggregates but did not show the same transmissibility in their experiments. Preparations from Parkinson's disease and dementia with Lewy bodies did not transmit a lethal synucleinopathy to the experimental mice. The finding suggests different strains or conformations of alpha-synuclein between MSA and Parkinson's disease, and has prompted research into anti-prion therapeutic strategies for synucleinopathies and raised concerns about the decontamination of neurosurgical instruments. The work was published in journals such as PNAS, establishing MSA as a distinct alpha-synuclein prion disease, and making it the second confirmed human prion disease after Creutzfeldt-Jakob disease. However, this does not mean MSA is contagious in ordinary contact, as it involves prion-like alpha-synuclein aggregates rather than infectious prions in the typical sense.

What each model said

  • Grok
    Yes. In 2015, Prusiner and colleagues published work (e.g., in PNAS) showing that α-synuclein aggregates purified from MSA brains act as prions: they propagate and transmit a lethal synucleinopathy when inoculated into transgenic mice expressing human α-synuclein, whereas equivalent preparations from Parkinson’s disease or dementia with Lewy bodies do not. This established MSA as a distinct α-synuclein prion disease.
  • GPT
    Yes. In 2015, researchers reported that misfolded **alpha-synuclein** in **multiple system atrophy (MSA)** behaves like a **prion**: it can self-propagate by inducing normal alpha-synuclein to misfold. Key point: this did **not** mean MSA is contagious in ordinary contact. It meant MSA involves **prion-like alpha-synuclein aggregates**, with evidence from transmission experiments in cell and mouse models.
  • Claude
    Yes. In 2015, Stanley Prusiner and colleagues at UCSF published a study in PNAS providing evidence that multiple system atrophy is caused by a prion form of alpha-synuclein. The team showed that brain extracts from MSA patients could transmit neurodegeneration to transgenic mice expressing mutated human alpha-synuclein and could infect cultured cells, behaving in a self-propagating manner characteristic of prions. This made MSA the second confirmed human prion disease, after Creutzfeldt-Jakob disease (and related conditions). The finding distinguished MSA from Parkinson's disease, which also i…
  • Gemini
    Yes, a significant discovery in 2015, led by Dr. Stanley Prusiner and his team, linked alpha-synuclein prions to multiple system atrophy (MSA). Their research, published in PNAS, demonstrated that aggregated alpha-synuclein in the brains of MSA patients behaves like a prion, capable of transmitting the disease to cell cultures and transgenic mice.

Models Used

  • Grok
  • GPT
  • Claude
  • Gemini

Disclaimer: This page summarizes the output of 4 frontier large-language models at a single point in time. NoParrot Score reflects cross-model consensus, not absolute truth. Models can be wrong, and consensus can be wrong with them. Treat this page as a research aid, not a final verdict.

Related Questions

Check your own claim

Send any question to 4 AI models at once. See where they agree and where they don't — with a NoParrot Score from 0 to 100 and claim-level highlights.

Try NoParrot Free